Truecaller’s latest valuation reset has seen its fair value estimate cut from roughly SEK 50.83 to SEK 39.17 per share, as analysts dial back their medium term growth optimism while still ...

If you are wondering whether Mineralys Therapeutics is still worth buying after its big run, you are not alone. This is exactly what we are going to unpack. The stock has pulled back about 12.1% over ...

While the Met Office has cast doubt on prospects of a white Christmas for most people, there’s a small chance that a ...